PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 91 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 42.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $4,000 | -98.1% | 1,828 | -97.8% | 0.00% | – |
Q4 2020 | $210,000 | -62.2% | 84,351 | -68.6% | 0.00% | -100.0% |
Q3 2020 | $555,000 | +795.2% | 268,672 | +1228.2% | 0.00% | – |
Q2 2020 | $62,000 | +37.8% | 20,228 | 0.0% | 0.00% | – |
Q1 2020 | $45,000 | +45.2% | 20,228 | +230.6% | 0.00% | – |
Q2 2018 | $31,000 | -42.6% | 6,119 | -23.1% | 0.00% | – |
Q1 2018 | $54,000 | -8.5% | 7,961 | 0.0% | 0.00% | – |
Q4 2017 | $59,000 | – | 7,961 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,360,000 | $6,895,000 | 5.06% |
Omega Fund Management, LLC | 778,230 | $3,946,000 | 2.91% |
BVF INC/IL | 5,346,838 | $27,108,000 | 2.65% |
Virtus ETF Advisers LLC | 152,550 | $773,000 | 0.68% |
SPHERA FUNDS MANAGEMENT LTD. | 842,632 | $4,272,000 | 0.59% |
Tekla Capital Management LLC | 2,087,380 | $10,583,000 | 0.40% |
Schonfeld Strategic Advisors LLC | 828,600 | $4,201,000 | 0.23% |
Orbimed Advisors | 3,140,000 | $15,920,000 | 0.19% |
Lombard Odier Asset Management (USA) Corp | 563,878 | $2,859,000 | 0.19% |
Rhenman & Partners Asset Management AB | 300,000 | $1,521,000 | 0.16% |